Developing cancer or precancerous changes
Potential benefit studied: Regression of precancerous lesions and possible cancer prevention
Supporting researchThis is cancer research, not a product treatment claim. These studies do not establish that Longevity or Mobility prevents, treats or cures cancer.
A randomized human trial found that curcumin produced more visible clinical responses in oral precancerous lesions than placebo.
A trial randomized 223 people with oral leukoplakia to 3.6 g daily curcumin or placebo for six months and measured clinical lesion response.
Neither trial tested Longevity or Mobility, and changes in lesions are not proof of fewer future cancers. These products should not replace recommended screening, surveillance or specialist management of precancerous conditions.
The doses above describe research, not personal dosing instructions. Ingredient studies do not diagnose symptoms or establish medical suitability. Discuss medicines, existing conditions and treatment decisions with an appropriate healthcare professional.